Wolters Kluwer Health Unveils Market-Leading Enhancements to Facts & Comparisons® eAnswers
Comparative EfficacyContent, Unlimited Number of Parenteral Drugs per Compatibility Check amongEnhancements Featured in Booth 405 at Florida Society of Health-SystemPharmacists
MINNEAPOLIS, MN — July 30, 2010 — Theaddition of comparative efficacy content and the ability to include anunlimited number of parenteral drugs in each compatibility check are two of themarket-leading enhancements to Facts& Comparisons® eAnswers unveiled by Wolters Kluwer Health today at theFlorida Society of Health-System Pharmacists (FSHP) Annual Meeting.
Wolters Kluwer Health, a leadingglobal provider of information for healthcare professionals and students, isfeaturing its newly enhanced drug reference product in Booth 405 at FSHP. The Annual Meeting is taking place July 30–Aug.1, 2010 in Buena Vista, Fla.
"Hospital pharmacists and nurses spoke, and they told us that they need acomprehensive tool that provides quick, accurate answers in a manner than fitstheir workflow," said Arvind Subramanian,President and CEO, Wolters Kluwer Health Clinical Solutions. "Our ComparativeEfficacy feature and other enhancements were made in direct response to this feedback."
Facts & Comparisons eAnswers addresses key hospital pharmacy pain points ofworkflow efficiency and patient safety by providing the tools and informationneeded to support drug dispensing activities. For retail pharmacies andacademia, it provides online access to the most up-to-date drug information andmedication management tools tailored to their unique needs, enabling bettertherapeutic decisions in less time.
The new comparative efficacy contentsummarizes available comparative information and provides guidance in choosingthe most appropriate medication for the patient. Comparative efficacy for anindividual drug is accessed in a subsection that contains summary informationfor the particular drug on one or more conditions, along with a brief summaryof all drugs used to treat the conditions. Each condition listed features alink to the full comparative efficacy monograph, which provides a literaturereview and summary of the safety, cost and therapeutic considerations forvarious drugs that have been used to treat the condition in question.
The IV-Chek feature, which provideshigh-quality compatibility information using Trissel's Tables, has also beenenhanced. Most notably, clinicians can now run compatibility checks on anunlimited number of parenteral drugs at one time and readability of theprintable compatibility chart has been improved with the addition of bordersand gridlines and landscape orientation. The output is also now available inPDF format.
About Wolters Kluwer Health
Wolters Kluwer Health (Philadelphia, PA)is a leading provider of information and business intelligence for students,professionals and institutions in medicine, nursing, allied health andpharmacy. Major brands include traditional publishers of medical and drugreference tools and textbooks, such as LippincottWilliams & Wilkins and Facts& Comparisons®; and electronic information providers, suchas Ovid®, UpToDate®,Medi-Span® and ProVation® Medical.
Wolters Kluwer Health is part ofWolters Kluwer, a market-leadingglobal information services company focused on professionals with annualrevenues (2009) of €3.4 billion ($4.8 billion), approximately 19,300 employeesworldwide and operations in over 40 countries across Europe, North America,Asia Pacific, and Latin America. Visit ourwebsite, YouTubeor follow @Wolters_Kluwer on Twitterfor more information about our market positions, customers, brands, andorganization.